MedDataX Logo

Sustainable and Healthy Return-to-Work Program - PRATICAdr 2.0

NCT06397326 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2024-05-02

No results posted yet for this study

Summary

This study aims to assess the effectiveness of PRATICAdr 2.0, a web application facilitated by a Return-to-Work Coordinator (RTW-C), with a focus on reducing sick leave duration and preventing relapse in individuals with CMDs. PRATICAdr 2.0 designed to enhance collaboration among Return-to-Work (RTW) stakeholders and provide systematic support throughout the RTW process, is evaluated in a randomized control trial (RCT). As part of the RCT, a total of 80 sick leave employees from 4 large public health organizations (n=80, 40 from the experimental group and 40 from the control group) will be recruited. The control group receives usual services offered by a RTW-C to sick leave employees, while the experimental group receives RTW-C services plus the use of PRATICAdr 2.0.

Conditions

  • Common Mental Disorder

Interventions

BEHAVIORAL

Return to work coordinator + PRATICAdr 2.0

The Return to work coordinator (RTW-C) uses PRATICAdr. 2.0 (web application).

BEHAVIORAL

Return to work coordinator only

The Return to work coordinator (RTW-C) intervenes on employees on sick leave as usual

Sponsors & Collaborators

  • Centre intégré de santé et de services sociaux (CISSS) de la Gaspésie

    collaborator UNKNOWN

  • Centre intégré de santé et de services sociaux (CISSS) de Laval

    collaborator UNKNOWN

  • Centre hospitalier de l'Université de Montréal (CHUM)

    collaborator OTHER

  • Centre intégré universitaire de santé et de services sociaux du Centre Ouest de Montréal

    collaborator UNKNOWN

  • Université du Québec a Montréal

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-06
Primary Completion
2026-04-15
Completion
2026-04-15

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06397326 on ClinicalTrials.gov